As of 11 March at 11:09:31 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

RBC Capital analyst Brian Abrahams maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) yesterday and set a price target of $65.00. The company’s shares closed yesterday ...

The men's Big Ten tournament is back, and this year's field might be one of its best yet. A first-of-its-kind conference tournament — only 15 of the conference's 18 programs qualified for it ...

Purdue's Braden Smith was named the Big Ten player of the year and Michigan State's Tom Izzo coach of the year by coaches and the media in voting coordinated by the conference. Smith and Izzo won ...

William Blair analyst Andy Hsieh reiterated a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today. The company’s shares opened today at $7.10. Effectively assess a stock's ...

A new life, a new season. Whichever way you want to put it, Rutgers has a chance to start fresh this week in the Big Ten Tournament after a disappointing regular season that fell well short of ...

NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $9.5 million in its fourth quarter. The Norwood, Massachusetts-based ...

President Donald Trump correctly noted Friday, as he has before, that Canada has tariffs above 200% on dairy products imported from the US. But Trump again failed to mention a critical fact. Trump ...

In the Big Ten, Michigan State earned top seed for the first time since 2019, finishing with 17 conference wins — the most in program history — en route to its 17th Big Ten regular season title.